| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/04/2004 | WO2003096966A3 Chimeric ige polypeptides and host cells |
| 03/04/2004 | WO2003083485A3 Protein for use in hypoxia related conditions |
| 03/04/2004 | WO2003082206A3 Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses |
| 03/04/2004 | WO2003074566A3 Rs7 antibodies |
| 03/04/2004 | WO2003070760A3 Anti-amyloid beta antibodies and their use |
| 03/04/2004 | WO2003068822A3 De-immunized (poly)peptide constructs |
| 03/04/2004 | WO2003062446A9 Mrp9 and its use detecting and treating cancer |
| 03/04/2004 | WO2003055980A3 Il-17 like molecules and uses thereof |
| 03/04/2004 | WO2003054018A3 Anti-tirc7 antibodies in therapy of inflammatory diseases |
| 03/04/2004 | WO2003054013A3 Compositions, methods and kits for detection and quantification of plant and animal source contaminants |
| 03/04/2004 | WO2003048301A3 Anti-hla-dr antibodies and the methods of using thereof |
| 03/04/2004 | WO2003048207A3 Anti-dota antibody |
| 03/04/2004 | WO2003044054A3 Peptides for the production of preparations for the diagnosis and therapy of autoimmun diseases |
| 03/04/2004 | WO2003042231A3 Bispecific anti-cd28 antibody molecule |
| 03/04/2004 | WO2003039225A3 Antigen arrays comprising rankl for treatment of bone disease |
| 03/04/2004 | WO2003037251A3 Hivgp120-induced bob/gpr15 activation |
| 03/04/2004 | WO2003019198A3 Methods relating to treatment of atherosclerosis |
| 03/04/2004 | WO2003019196A3 Diagnosis and treatment of atherosclerosis |
| 03/04/2004 | WO2003000846A3 A novel g protein-coupled receptor, gave 3 |
| 03/04/2004 | WO2002100900A3 Human recombinant antibody against the hepatitis c (hcv) non structural ns3 protein, nucleic acid and uses thereof |
| 03/04/2004 | WO2002092762A3 Cytokine polypeptides |
| 03/04/2004 | WO2002087611B1 Agent of human origin for vaccination against gd2 positive tumours |
| 03/04/2004 | WO2002085944A3 Single chain camelid vhh antibodies, method for their production in a mammal and their uses |
| 03/04/2004 | WO2002082091A3 Method for identification of proteins from intracellular bacteria |
| 03/04/2004 | WO2002078640A3 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 03/04/2004 | WO2002050550A3 Oxidised low-density lipoproteins (ldl) fractions |
| 03/04/2004 | WO2002020762A8 Tnf receptor-like molecules and uses thereof |
| 03/04/2004 | WO2002014352A9 Therapeutic compounds for ovarian cancer |
| 03/04/2004 | WO2002012502A9 Anti-tnf antibodies, compositions, methods and uses |
| 03/04/2004 | US20040044194 Aggrecanase molecules |
| 03/04/2004 | US20040044188 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 03/04/2004 | US20040044187 Chimeric immunoglobulin for prevention and treatment blood, tumor, cardiovascular and urogenital disorders |
| 03/04/2004 | US20040044185 Comprises transmembrane protein for use in liposome-based drug and nucleotide delivery systems; gene therapy |
| 03/04/2004 | US20040044184 Comprises cytoskeletal protein for diagnosis, prevention and treatment of cell proliferative, viral and neurodegenerative diseases |
| 03/04/2004 | US20040043935 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
| 03/04/2004 | US20040043929 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer |
| 03/04/2004 | US20040043457 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/04/2004 | US20040043424 Immunoglobulin superfamily proteins |
| 03/04/2004 | US20040043418 Humanized antibodies that sequester Abeta peptide |
| 03/04/2004 | US20040043411 DSP-11 dual-specificity phosphatase |
| 03/04/2004 | US20040043406 Reagents and methods useful for detecting diseases of the gastrointestinal tract |
| 03/04/2004 | US20040043402 Interferon-alpha induced gene |
| 03/04/2004 | US20040043401 Nucleic acids encoding chimeric T cell receptors (TCRs), methods of using them to facilitate a T cell response to a selected target |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043391 Leptospira vaccine antigens for the prevention of Leptospirosis |
| 03/04/2004 | US20040043381 Multiple sclerosis associated retrovirus (MSRV) -1 ; long terminal repeat sequences (LTR) |
| 03/04/2004 | US20040043029 Novel antibodies reactive with human carcinomas |
| 03/04/2004 | US20040043028 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid |
| 03/04/2004 | US20040043026 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 03/04/2004 | US20040043020 Induction immunology response in poultry; harvesting eggs containing antibodies; controlling acidosis |
| 03/04/2004 | US20040043019 Administering immunoglobulins; antihistamines, antiarthritic agents; autoimmune disease |
| 03/04/2004 | US20040042998 Induce migration of skin cells; antiinflammatory agents |
| 03/04/2004 | CA2496952A1 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins |
| 03/04/2004 | CA2496572A1 Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
| 03/04/2004 | CA2496485A1 Use of an anti-g-csf or anti-g -csfr antibody or a soluble g- csfr for the treatment or prophylaxis of arthritis |
| 03/04/2004 | CA2496422A1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor |
| 03/04/2004 | CA2496272A1 Integrin b6 markers for compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer |
| 03/04/2004 | CA2496236A1 Preventives/remedies for cancer |
| 03/04/2004 | CA2495849A1 Ptk7 protein involvement in carcinoma |
| 03/04/2004 | CA2495198A1 Novel lipases and uses thereof |
| 03/04/2004 | CA2494974A1 Il-7 drug substance, composition, preparation and uses |
| 03/03/2004 | EP1394551A2 Integrin as a predictor of endometriosis |
| 03/03/2004 | EP1394263A1 Method of detecting and separating undifferentiated liver cellss using dlk |
| 03/03/2004 | EP1394261A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
| 03/03/2004 | EP1394256A2 HCV genomic sequences for diagnostics and therapeutics |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394253A1 Anti-human ovarian cancer -anti-cd3 bispecific antibody |
| 03/03/2004 | EP1394184A1 Apoptose inhibitor |
| 03/03/2004 | EP1394183A1 Purification of polyreactive autoantibodies and uses thereof |
| 03/03/2004 | EP1393776A1 Use of genes identified to be involved in tumor development for the development of anti-cancer drugs and diagnosis of cancer |
| 03/03/2004 | EP1393750A2 Conjugates for treating an immune disease |
| 03/03/2004 | EP1393746A1 Human polyclonal antibody compositions |
| 03/03/2004 | EP1393743A1 Agents modulating UPA/UPAR activity for the treatment of AIDS |
| 03/03/2004 | EP1392866A2 Novel method for cloning variable domain sequences of immunological gene repertoire |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392859A2 Isolating cells expressing secreted proteins |
| 03/03/2004 | EP1392852A2 Nucleic acid-associated proteins |
| 03/03/2004 | EP1392845A2 A g-protein coupled receptor and uses therefor |
| 03/03/2004 | EP1392844A2 Use of hmg fragments as anti-inflammatory agents |
| 03/03/2004 | EP1392829A2 Compositions and methods relating to lung specific genes and proteins |
| 03/03/2004 | EP1392826A2 Bifunctional fusion proteins with glucocerebrosidase activity |
| 03/03/2004 | EP1392815A2 Enzymes having alpha amylase activity and methods of use thereof |
| 03/03/2004 | EP1392734A1 Hevein-binding monoclonal antibodies |
| 03/03/2004 | EP1392733A2 Mammalian tumor susceptibility gene products and their uses |
| 03/03/2004 | EP1392728A2 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 03/03/2004 | EP1392725A1 Nonhuman pregnane x receptor sequences for use in comparative pharmacology |
| 03/03/2004 | EP1392719A2 Forms of prostate specific antigens and methods for their detection |
| 03/03/2004 | EP1392361A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26 |
| 03/03/2004 | EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof |
| 03/03/2004 | EP1392359A2 Specific binding proteins and uses thereof |
| 03/03/2004 | EP1392358A2 Immunogenic tumor antigens: nucleic acids and polypeptides encoding the same and methods of use thereof |
| 03/03/2004 | EP1392356A1 Chimeric human leukocyte antigen and epitope-bearing molecules having immunosuppressant activity |
| 03/03/2004 | EP1392354A2 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 03/03/2004 | EP1392340A2 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 03/03/2004 | EP1392204A2 Bifunctional energy-reversible acyl-compositions |
| 03/03/2004 | EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy |
| 03/03/2004 | EP1023467B1 Method for measuring viral infectivity |
| 03/03/2004 | EP0964875B1 5-hydroxytryptophol (5-htol) derivatives, antibodies, immunoassays and detection of recent alcohol consumption |